期刊文献+

马铃薯三糖熊果酸衍生物抑制H5N1流感病毒进入靶细胞 被引量:5

3-O-β-chacotriosyl benzyl ursolate inhibits entry of H5N1 influenza virus into target cells
下载PDF
导出
摘要 目的研究马铃薯三糖熊果酸衍生物能否通过抑制H5N1流感病毒进入靶细胞,作为潜在的新型抗流感药物进行研发。方法以马铃薯三糖熊果酸甲酯1为先导化合物,设计并合成4个目标化合物,利用建立的H5N1假病毒活性检测方法,测试化合物的抑制活性。结果化合物1b,1c和1d对源自A/Thailand/Kan353/2004的H5N1假病毒毒株有明显的抑制作用且化合物1 d的活性最好,其IC50达到0.96±0.10μmol/L。结论初步构效关系研究表明,熊果酸的C-17位羧基被酯化后可显著提高其抗病毒活性;将羧基转化成酰胺后可提高抗病毒活性并降低对靶细胞MDCK的细胞毒性。 Objective To study the inhibitory activities of 3-O-β-chacotriosyl benzyl ursolate and its derivatives as potential new anti-influenza virus agents against the entry of H5N1 influenza viruses into the target cells. Methods Four target compounds were designed and synthesized, which were structurally related to the lead compound 3-O-β-chacotriosyl methyl ursolate(1).The inhibitory activities of these compounds were tested at a cellular level psuedovirus system targeting H5N1 influenza viruse entry. Results and Conclusion The compounds 1b, 1c and 1d showed potent inhibitory activities against the entry of A/Thailand/Kan353/2004 pseudovirus into the target cells, and among them compound 1d showed the strongest inhibitory activity with an IC50 value of 0.96±0.10 μmol/L. The structure-activity relationship analysis of these compounds indicated that when 17-COOH of ursolic acid was esterified, introduction of Me groups rather than aryl groups more strongly enhanced the inhibitory activity. Changing 17- COOH of ursolic acid into amide could increase the antiviral activity and decrease the cytotoxicity of the compounds in MDCK cells.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2015年第6期789-794,共6页 Journal of Southern Medical University
基金 国家自然科学基金(21202047 U1301224) 广东省自然科学基金博士启动项目(S2012040007711) 广东高校优秀青年创新人才培养计划项目(LYM10037) 高等学校博士学科点专项科研基金(新教师类)(20114404120016)~~
关键词 H5N1 流感病毒进入抑制剂 血凝素 五环三萜 H5N1 avian influenza virus influenza virus entry inhibitor hemagglutinin pentacyclic triterpenoids
  • 相关文献

参考文献24

  • 1Schade D,Kotthaus J, Riebling L, et al. Development of novelpotent orally bioavailable oseltamivir derivatives active againstresistant influenza A[J]. J Med Chem, 2014,57(3): 759-69.
  • 2Liu S, Li R,Zhang R, et al. CL-385319 inhibits H5N1 avianinfluenza A virus infection by blocking viral entry [J]. Eur JPharmacol, 2011,660(2/3): 460-7.
  • 3An J, Lee DC, Law AH, et al. A novel small-molecule inhibitor ofthe avian influenza H5N1 virus determined through computationalscreening against the neuraminidase[J]. J Med Chem, 2009, 52(9):2667-72.
  • 4Neumann G, Noda T,Kawaoka Y. Emergence and pandemicpotential of swine-origin H1N1 influenza virus [J]. Nature, 2009,459(7249): 931-9.
  • 5Hsieh HP,Hsu JT. Strategies of development of antiviral agentsdirected against influenza virus replication [J]. Curr Pharm Des,2007,13(34): 3531-42.
  • 6Zhu Z, Li R, Xiao G, et al. Design, synthesis and structure-activityrelationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion[j]. Eur J Med Chem, 2012,57: 211-6.
  • 7Pinto LH, Holsinger LJ, Lamb RA. Influenza virus M2 protein hasion Channel activity[j]. Cell, 1992, 69(3): 517-28.
  • 8Bright RA, Medina MJ, Xu X,et al. Incidence of adamantaneresistance among influenza A (H3N2) viruses isolated worldwidefrom 1994 to 2005: a cause for concern [J]. Lancet, 2005, 366(9492): 1175-81.
  • 9Gupta RK, Nguyen-Van-Tam JS. Oseltamivir resistance in influenzaA (H5N1) infection [J]. N Engl J Med, 2006,354(13): 1423-4;author reply 1423-4.
  • 10Moscona A. Global transmission of oseltamivir-resistant influenza[J]. N Engl J Med, 2009, 360(10): 953-6.

二级参考文献16

  • 1Morens DM,Fauci AS. The 1918 influenza pandemic:insights for the 21st century[J].Journal of Infectious Diseases,2007,(07):1018-1028.
  • 2Kobasa D,Jones SM,Shinya K. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus[J].NATURE,2007,(7125):319-323.
  • 3Weinstock DM,Zuccotti G. Adamantane resistance in influenza A[J].JAMA:the Journal of the American Medical Association,2006,(08):934-936.
  • 4Saito R,Li D,Suzuki H. Amantadine-resistant influenza A(H3N2) virus in Japan,2005-2006[J].New England Journal of Medicine,2007,(03):312-313.
  • 5Rameix-Welti MA,Agou F,Buchy P. Natural variation can significantly alter the sensitivity of influenza A(H5N1)viruses to oseltamivir[J].Antimicrobial Agents and Chemotherapy,2006,(11):3809-3815.
  • 6Vanderlinden E,G?ktas F,Cesur Z. Novel inhibitors of influenza virus fusion:structure-activity relationship and interaction with the viral hemagglutinin[J].Journal of Virology,2010,(09):4277-4288.
  • 7Song JM,Park KD,Lee KH. Biolog ical evaluation of an ti in fluenza viral activity of sem i synthetic catechin d erivatives[J].Antiviral Research,2007,(02):178-185.
  • 8Cianci C,Yu KL,Dischino DD. pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion[J].Journal of Virology,1999,(03):1785-1794.
  • 9Staschke KA,Hatch SD,Tang JC. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid[J].Journal of Virology,1998,(02):264-274.
  • 10Tang GZ,Lin XF,Qiu ZX. Design and synthesis of benzenesulfonamide derivatives as potent Anti-Influenza hemagglutinin inhibitors[J].ACS Med Chem Lett,2011,(08):603-607.

共引文献2

同被引文献17

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部